Drug Pipeline

FDG Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
4
Recruiting
2
Phase 3
6
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2/3
1
Phase 2
2
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04943211 Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in… Histiocytosis Recruiting
Phase 2/3
NCT05015881 Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder Alcohol Use Disorder (AUD) Enrolling by Invitation
Phase 2
NCT06335888 A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis Giant Cell Arteritis Recruiting
NCT04692103 Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted… Estrogen Receptor Positive Active, Not Recruiting
Not specified
NCT03507257 Longitudinal Early-onset Alzheimer's Disease Study Protocol Early Onset Alzheimer Disease Recruiting
NCT06630845 Comparison of Whole Body DWI to FDG PET Metastatic Cancer Recruiting
Sponsors Running FDG Trials
Indiana University (1) University of Washington (1) Anna Raciborska (1) University of Pennsylvania (1) Insel Gruppe AG, University Hospital Bern (1) University of California, San Francisco (1)
Disease Areas
Alzheimer's Disease (1) Breast Cancer (1)
Get alerts when FDG trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free